Bacteriolytic therapy may be a promising treatment strategy for advanced pancreatic cancer patients

Aug 02, 2010

Pancreatic carcinoma is only rarely curable. A German research group investigated an alternative treatment using spores of the bacterium Clostridium novyi in an animal model. Tumors of a defined medium size were successfully treated. Small tumors remained unaffected and the treatment was toxic for animals with very large tumors. Successful treatment was due to the induction of an immune response predominantly the innate arm of the immune system.

The aim of cancer immunotherapy is the stimulation of immune mechanisms to recognize and may be a useful complementary therapy to conventional anticancer therapy. Immunotherapy was initiated over 100 years ago when New York surgeon William B. Coley inoculated a bacterial vaccine consisting of Streptococcus pyogenes and Serratia marcescens. Several patients experienced a beneficial effect on malignancy and were finally cured of their tumours by the development of a potent immune response.

A research article to be published on July 28,2010 in the worked on this old idea. The research team led by Dr. Michael Linnebacher from the University of Rostock treated pancreatic carcinoma with Clostridium novyi-spores. In their experimental model they analyzed animals with tumours of different sizes. Treatment success depended on tumour size. Small tumours were completely unaffected whereas the treatment was toxic in cases of very large tumours. Most interestingly, tumours of a defined medium size completely disappeared and animals remained free of tumour recurrence. The authors showed that immune mechanisms were responsible for this success.

The bacterial spores germinate and grow in the oxygen-free tumour centres where they damage surrounding . This together with an infection-driven infiltration of tumours by cells of the leads to significant damage to tumours.

These data indicate that the application of bacteria may be a promising treatment strategy for patients with advanced pancreatic cancer and warrants further investigation.

Explore further: Patients with advanced, incurable cancer denied palliative care

More information: Maletzki C, Gock M, Klier U, Klar E, Linnebacher M. Bacteriolytic therapy of experimental pancreatic carcinoma. World J Gastroenterol 2010; 16(28): 3546-3552 www.wjgnet.com/1007-9327/full/v16/i28/3546.htm

add to favorites email to friend print save as pdf

Related Stories

Scientists discover how to improve immune response to cancer

Apr 26, 2009

A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer ...

A new cancer vaccine starves tumors of blood

May 24, 2010

A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.

Drug shrinks lung cancer tumors in mice

Nov 10, 2009

(PhysOrg.com) -- A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer ...

Recommended for you

User comments : 0